We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Taro Pharmaceutical Industries’ Canadian manufacturing site has received FDA approval for its ANDA for a generic version of Sanofi-Aventis’ acne drug Klaron 10 percent.